Telehealth GLP-1 boom raises safety questions worth watching
Posted by quiet_ironman in Research & News - 3 points, 2 comments.
The USNews piece looks at how telehealth providers are rushing to meet exploding demand for GLP-1 drugs like semaglutide, while medication errors and oversight gaps are also climbing. It cites a KFF Health News review of FDA reports showing a spike in adverse events linked to these remote prescriptions.
For me the article hits a nerve because I’ve seen friends jump on GLP-1 telehealth scripts without basic labs or follow‑up, then struggle with nausea or low blood sugar that could have been caught earlier. The convenience is real, but the piece reminds me that safety nets like routine metabolic panels and clinician check‑ins shouldn’t be optional just because the visit is virtual.
What do you think, should telehealth GLP-1 platforms be required to mandate at least one in‑person visit or specific lab work before prescribing, or is the current flexibility enough to keep access broad while minimizing risk?
Comments
- runner_aaron: Tbh I think the answer is somewhere in the middle. The convenience angle is real, and an in-person mandate would hurt access for a lot of people who actually use these responsibly. But requiring baseline bloods, A1c, and a follow-up panel at 3 months seems like a no-brainer. Plenty of providers already do this, the ones cutting corners are the problem. Where I sit though, the bigger issue is people starting strong GLP-1 doses with zero work done beforehand, then wondering why they're curled up
- quiet_ironman: Yeah, the slow titration thing is exactly what burns me. I watched a buddy start at what I'd consider a full dose right out of the gate because the telehealth provider just rubber stamped the script. 🤮 No coaching on what to eat that first week, nothing about injection site reactions, no "here's what to do if you can't keep water down for 36 hours." Just "congrats, here's your pen." Baseline bloods plus a 3 month follow up panel like you said feels like the minimum, and honestly any provider s
Community discussion - research and educational context only. Not medical advice.